FR2814367B1 - Ligands du recepteur npff pour le traitement de la douleur et des hyperalgies - Google Patents

Ligands du recepteur npff pour le traitement de la douleur et des hyperalgies

Info

Publication number
FR2814367B1
FR2814367B1 FR0012164A FR0012164A FR2814367B1 FR 2814367 B1 FR2814367 B1 FR 2814367B1 FR 0012164 A FR0012164 A FR 0012164A FR 0012164 A FR0012164 A FR 0012164A FR 2814367 B1 FR2814367 B1 FR 2814367B1
Authority
FR
France
Prior art keywords
hyperalgia
pain
treatment
receptor ligands
npff receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0012164A
Other languages
English (en)
Other versions
FR2814367A1 (fr
Inventor
Jean Jacques Bourguignon
Jean Paul Macher
Martine Schmitt
Guy Simonnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Santé et de la Recherche Médicale
Original Assignee
Institut National de la Santé et de la Recherche Médicale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Santé et de la Recherche Médicale filed Critical Institut National de la Santé et de la Recherche Médicale
Priority to FR0012164A priority Critical patent/FR2814367B1/fr
Priority to AU2001291994A priority patent/AU2001291994A1/en
Priority to PCT/FR2001/002973 priority patent/WO2002024192A1/fr
Publication of FR2814367A1 publication Critical patent/FR2814367A1/fr
Application granted granted Critical
Publication of FR2814367B1 publication Critical patent/FR2814367B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0012164A 2000-09-25 2000-09-25 Ligands du recepteur npff pour le traitement de la douleur et des hyperalgies Expired - Fee Related FR2814367B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0012164A FR2814367B1 (fr) 2000-09-25 2000-09-25 Ligands du recepteur npff pour le traitement de la douleur et des hyperalgies
AU2001291994A AU2001291994A1 (en) 2000-09-25 2001-09-25 Dipeptide ligands of the npff receptor for treating pain and hyperalgesia
PCT/FR2001/002973 WO2002024192A1 (fr) 2000-09-25 2001-09-25 Ligands dipeptidiques du recepteur npff pour le traitement de la douleur et des hyperalgies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0012164A FR2814367B1 (fr) 2000-09-25 2000-09-25 Ligands du recepteur npff pour le traitement de la douleur et des hyperalgies

Publications (2)

Publication Number Publication Date
FR2814367A1 FR2814367A1 (fr) 2002-03-29
FR2814367B1 true FR2814367B1 (fr) 2008-12-26

Family

ID=8854636

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0012164A Expired - Fee Related FR2814367B1 (fr) 2000-09-25 2000-09-25 Ligands du recepteur npff pour le traitement de la douleur et des hyperalgies

Country Status (3)

Country Link
AU (1) AU2001291994A1 (fr)
FR (1) FR2814367B1 (fr)
WO (1) WO2002024192A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276249B2 (en) 2002-05-24 2007-10-02 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
JPWO2004080965A1 (ja) * 2003-03-14 2006-06-08 協和醗酵工業株式会社 ニューロペプチドｆｆ受容体拮抗剤
CL2004000553A1 (es) 2003-03-20 2005-02-04 Actelion Pharmaceuticals Ltd Uso de compuestos derivados de guanidina como antagonistas del receptor de neuropeptido ff; compuestos derivados de guanidina; procedimientos de preparacion; y composicion farmaceutica que los comprende.
FI20031454A0 (fi) 2003-10-06 2003-10-06 Juvantia Pharma Ltd Oy Selektiivisiä somatostatiinireseptori 1 ja/tai 4 -agonisteja ja -antagonisteja
EP2669276A1 (fr) 2012-05-31 2013-12-04 Université de Strasbourg Dérivés d'ornithine et de lysine pour le traitement de la douleur
BR112020001157A2 (pt) * 2017-07-21 2020-07-21 Sichuan Haisco Pharmaceutical Co., Ltd. compostos de peptídeo amida, método de preparação dos mesmos e uso em medicina
KR20200118005A (ko) 2018-02-05 2020-10-14 위니베르시떼 드 스트라스부르 통증 치료용 화합물 및 조성물
EP4010328A1 (fr) 2019-08-06 2022-06-15 Domain Therapeutics Composés de 5-hétéroaryl-pyridin-2-amine en tant qu'antagonistes du récepteur du neuropeptide ff

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4326465A1 (de) * 1993-01-20 1995-02-09 Thomae Gmbh Dr K Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
GB9500601D0 (en) * 1995-01-12 1995-03-01 Wellcome Found Modified peptides
DE19544686A1 (de) * 1995-11-30 1997-06-05 Thomae Gmbh Dr K Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US6262246B1 (en) * 1998-09-25 2001-07-17 Synaptic Pharmaceutical Corporation DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof

Also Published As

Publication number Publication date
FR2814367A1 (fr) 2002-03-29
WO2002024192A1 (fr) 2002-03-28
AU2001291994A1 (en) 2002-04-02

Similar Documents

Publication Publication Date Title
MA26852A1 (fr) Agonistes selectifs du recepteur ep4 pour le traitement de l'osteoporose
EP1438062A4 (fr) Methodes et compositions pour le traitement de lesions cutanees
EP1274444A4 (fr) Composes servant a traiter des troubles psychiatriques ou des troubles provoques par la consommation abusive de substances psychoactives
FR13C0060I2 (fr) Omega-carboxyaryldiphenyluree fluoro-subtituee pour le traitement et la prevention de maladies et d'etats pathologiques
EP1370211A4 (fr) Co-administration de l'agoniste du recepteur de la melanocortine et inhibiteur de phosphodiesterase pour le traitement de troubles associes a l'amp cyclique
EP1471874A4 (fr) Compositions et procedes d'administration pour le traitement des rides, des ridules et de l'hyperhidrose
DE60138129D1 (de) Apparat zur behandlung von zähnen
EP1300963A4 (fr) Appareil de traitement d'echos
EP1311261A4 (fr) Medicaments pour le traitement chimiotherapeutique de maladies
DZ3209A1 (fr) Antagonistes selectifs du recepteur iGLuR5 utilises dans le traitement de la migraine.
DZ3442A1 (fr) Combinaison de fenofibrate et de coenzyme q10 pour le traitement de dysfonctionnement endothelial
NO20042208L (no) Vaginalt administrerte anti-dysrytmiske midler for behandling av bekkensmerter
FR2816513B1 (fr) Valve sous-cutanee pour le traitement de l'hydrocephalie et ses dispositifs de reglage
MA25234A1 (fr) Vibromasseur pour le soulagement des maux et de la douleur.
FR2815541B1 (fr) Utilisation d'inhibiteurs de l'apoptose des pericytes pour le traitement et/ou la prevention de la retinopathie diabetique
EP1442062A4 (fr) Methodes de traitement du carcinome
EP0771563A3 (fr) Utilisation des ligandes de recepteur 5-HT1A pour le traitement du glaucome
FR2818917B1 (fr) Filtre pour la depollution particulaire des fluides
FR2778330B1 (fr) Appareil pour le traitement orthodontique
EP1359885A4 (fr) Inhibiteurs de nos pour le traitement des rides
EP1187605A4 (fr) Traitement de pathologies non malignes par antagonistes de ras
EP1830873A4 (fr) Glyponectine (adiponectine glycosylee) pour le traitement de maladies et d'etats pathologiques
EP0761604A3 (fr) Agent pour le traitement des eaux
EP1161255A4 (fr) Procedes et compositions pour le traitement de la dyserection
EP1448193A4 (fr) Composes therapeutiques pour le traitement d'etats dyslipidemiques

Legal Events

Date Code Title Description
TQ Partial transmission of property
TQ Partial transmission of property
ST Notification of lapse

Effective date: 20120531